ora organic glp 1 Orforglipron: Eli Lilly's New Oral GLP-1 Weight-loss Pill Orforglipron FDA Approval: Why the

A phase I study to evaluate IDE-397 in solid tumors is currently underway (NCT04794699) (Table 1)

How should I manage a patient on a GLP1 receptor agonist (GLP1 RA) who has a thyroid nodule scheduled for ultrasound monitoring in 12 months?

Glutathione and glutathione-related enzymes in research subjects cataractous lenses [PMID: 1945285] Laboratory literature summary: Glutathione and glutathione-related enzymes in research subjects cataractous lenses

PMID: 2739055 Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM